AI assistant
Merck & Co., Inc. — Director's Dealing 2025
May 2, 2025
284_dirs_2025-05-02_7b468e08-0907-43d3-a57a-1e75a3f1108c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-30
Reporting Person: Romanelli Joseph (President, Human Health Int?l)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-30 | Common Stock | M | 2063 | $84.71 | Acquired | 22815.545 | Direct |
| 2025-04-30 | Common Stock | F | 1017 | $84.71 | Disposed | 21798.545 | Direct |
| 2025-05-02 | Common Stock | M | 2262 | $83.26 | Acquired | 24060.545 | Direct |
| 2025-05-02 | Common Stock | F | 1115 | $83.26 | Disposed | 22945.545 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-30 | Restricted Stock Unit | $ | M | 2063 | Disposed | 2027-04-30 | Common Stock (2063) | Direct |
| 2025-05-02 | Restricted Stock Unit | $ | M | 2262 | Disposed | 2026-05-02 | Common Stock (2262) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.